"O Instituto Ganz Sanchez é o primeiro centro latinoamericano de investigação e tratamento de zumbido no ouvido e intolerância a sons (hiperacusia e misofonia). Também atende pacientes com perda auditiva, tontura, ouvido tampado e distúrbios do sono. Foi fundado em 2009 pela Dra. Tanit Ganz Sanchez, que é Professora Livre-Docente pela Faculdade de Medicina da USP e pioneira no desenvolvimento de pesquisas científicas e na criação de inúmeras ações de conscientização sobre zumbido no Brasil, desde 1994. O Instituto Ganz Sanchez situa-se em local privilegiado de São Paulo. A equipe de médicas e fonoaudiólogas especializadas é escolhida a dedo e já foi reconhecida pelo conhecimento, cordialidade e eficiência."

During the past decade, Instituto Ganz Sanchez conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Ganz Sanchez" are "Subjective Tinnitus" (2 trials). Many other conditions were trialed in "Instituto Ganz Sanchez" in a lesser frequency.

Most popular intervention types in "Instituto Ganz Sanchez" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Neramexane mesylate" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Ganz Sanchez" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Ganz Sanchez". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Ganz Sanchez, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Ganz Sanchez, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".